ArticleTherapeutic advances in medical oncology2020

FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules.

Francesca Foschini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.